Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Cholesterol

Pharmaceuticals

New cholesterol-buster from Esperion now available in U.S.

ANN ARBOR—Esperion Therapeutics Inc. (NASDAQ: ESPR), developers of novel treatments to reduce cholesterol in the bloodstream, announced the United States commercial availability of Nexlizet tablets. Nexlizet is a combination of …

Clinical Trials / Pharmaceuticals

Esperion sees positive results from final study on cholesterol-buster

ANN ARBOR — Esperion Therapeutics Inc. (Nasdaq: ESPR), the Ann Arbor-based pharmaceutical developer, announced positive results from the final Phase 3 test of its lead drug candidate, bempedoic acid. The …

Read the magazine:

TechCentury
Advertise or Contribute an Article
Lawrence Technological University

Subscribe to TechCentury.com

Top Posts

  • MSU Offers Rare Public Visit In Next-Generation Atom Smasher
  • Cable TV's Charter Orders 800+ Ford Transit Vans
  • Madison Heights firm rolls out self-driving car motherboard at CES 2019
  • Whirlpool sells home-brewing appliance to startup
  • Great Lakes Health Connect partners with data exchange firm

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT